Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
New Profit is a venture philanthropy organization that provides unrestricted funding and strategic support to social entrepreneurs driving systemic change in the United States. While not a traditional biotechnology company, New Profit maintains a significant focus on health equity, investing in innovative models that expand access to care and improve health outcomes for underserved communities. The organization operates by identifying high-impact social enterprises and providing them with multi-year financial backing and leadership development. Through its Health Equity cohort and various initiatives, New Profit aims to dismantle barriers to health and well-being at a national level.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on New Profit.